000 | 01170 a2200349 4500 | ||
---|---|---|---|
005 | 20250515032205.0 | ||
264 | 0 | _c20061212 | |
008 | 200612s 0 0 eng d | ||
022 | _a0387-7604 | ||
024 | 7 |
_a10.1016/j.braindev.2006.05.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMazzone, Luigi | |
245 | 0 | 0 |
_aTopiramate in children with autistic spectrum disorders. _h[electronic resource] |
260 |
_bBrain & development _cNov 2006 |
||
300 |
_a668 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Letter; Comment | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAutistic Disorder _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFructose _xanalogs & derivatives |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTopiramate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aRuta, Liliana | |
773 | 0 |
_tBrain & development _gvol. 28 _gno. 10 _gp. 668 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.braindev.2006.05.004 _zAvailable from publisher's website |
999 |
_c16391263 _d16391263 |